Syros Pharmaceuticals, Inc.
Total Trades
16
Buys
2
Sells
13
Largest Trade
N/A
Insiders
10
Institutional Funds
2
Inst. Value
$1K–$15K
Activist Filings
35
Insider Trades
| Insider | Title | Type | Value | Shares | Price | Date |
|---|---|---|---|---|---|---|
| Simonian Nancy A | Director | SELL | $1K–$15K | 37K | $0.27 | Dec 4, 2024 |
| Simonian Nancy A | Director | SELL | $15K–$50K | 135K | $0.27 | Nov 27, 2024 |
| Stephens Kristin | Chief Development … | SELL | $1K–$15K | 36K | $0.22 | Nov 20, 2024 |
| Roth David | Chief Medical Offi… | SELL | $1K–$15K | 12K | $0.20 | Nov 20, 2024 |
| Quirk Gerald E | Chief Legal & Comp… | SELL | $1K–$15K | 47K | $0.22 | Nov 20, 2024 |
| Chee Conley | President & CEO | SELL | $15K–$50K | 135K | $0.20 | Nov 20, 2024 |
| Haas Jason | CFO | SELL | $15K–$50K | 138K | $0.21 | Nov 20, 2024 |
| Young Richard A | Director | SELL | $100K–$500K | 35K | $5.12 | Jul 2, 2024 |
| Roth David | Chief Medical Offi… | SELL | $50K–$100K | 10K | $4.95 | Apr 5, 2024 |
| Roth David | Chief Medical Offi… | SELL | <$1K | 150 | $4.98 | Apr 2, 2024 |
| Roth David | Chief Medical Offi… | EXERCISE | N/A | 15K | — | Apr 2, 2024 |
| AKKARAJU SRINIVAS | Director | BUY | $1M+ | 905K | $4.42 | Dec 26, 2023 |
| Roth David | Chief Medical Offi… | SELL | $15K–$50K | 7K | $3.95 | Aug 2, 2023 |
| Olson Eric R | Chief Scientific O… | SELL | $1K–$15K | 689 | $3.50 | Jul 19, 2023 |
| TYSON TIMOTHY | Director | BUY | $100K–$500K | 17K | $6.26 | Oct 3, 2022 |
| Olson Eric R | Chief Scientific O… | SELL | $1K–$15K | 2K | $3.47 | Jan 6, 2022 |
Institutional Ownership
13F filings as of Mar 31, 2025 · 2 funds holding
| Fund | Shares | Value | Type |
|---|---|---|---|
| ACADIAN ASSET MANAGEMENT LLC | 330K | $1K–$15K | SH |
| FNY Investment Advisers, LLC | 16K | N/A | SH |
Activist & 5%+ Owners
SC 13D/13G filings — investors holding 5%+ of outstanding shares
SC 13D/A · Mar 27, 2025
2.6%
707K shares
Point72 Asset Management, L.P.
SC 13G/A · Feb 14, 2025
0.0%
496 shares
Avidity Partners Management LP
SC 13G/A · Feb 14, 2025
7.6%
2.0M shares
SC 13G/A · Feb 14, 2025
0.0%
0 shares
SC 13G/A · Feb 12, 2025
3.8%
1.1M shares
Adage Capital Management, L.P.
SC 13G/A · Feb 12, 2025
2.0%
532K shares
Avidity Partners Management LP
SC 13G/A · Nov 14, 2024
9.9%
2.9M shares
Bain Capital Life Sciences Fund II, L.P. 2
SC 13G/A · Nov 14, 2024
10.0%
2.8M shares
SC 13G/A · Nov 14, 2024
1.9%
516K shares
SC 13G/A · Nov 12, 2024
9.9%
343.7M shares
SC 13G/A · Aug 2, 2024
9.9%
3.6M shares
SC 13G · Feb 15, 2024
5.7%
1.5M shares
Avidity Partners Management LP
SC 13G/A · Feb 14, 2024
9.9%
2.7M shares
Ally Bridge MedAlpha Master Fund L.P.
SC 13G/A · Feb 14, 2024
2.6%
571K shares
Bain Capital Life Sciences Fund II, L.P. 2
SC 13G/A · Feb 13, 2024
10.0%
2.7M shares
SC 13G/A · Feb 9, 2024
9.9%
356.9M shares
Point72 Asset Management, L.P.
SC 13G · Jan 2, 2024
5.7%
1.5M shares
SC 13D/A · Dec 26, 2023
9.5%
2.5M shares
SC 13D · Oct 20, 2023
7.4%
1.6M shares
Avidity Partners Management LP
SC 13G/A · Feb 14, 2023
9.9%
2.1M shares
Bain Capital Life Sciences Fund II, L.P.
SC 13G/A · Feb 14, 2023
10.0%
2.1M shares
SC 13G/A · Feb 11, 2023
7.2%
1.5M shares
Ally Bridge MedAlpha Master Fund L.P.
SC 13G/A · Jan 27, 2023
6.9%
1.4M shares
SC 13G · Jan 25, 2023
6.0%
1.3M shares
SC 13G/A · Nov 10, 2022
0.5%
105K shares
Avidity Partners Management LP
SC 13G · Sep 20, 2022
9.9%
2.1M shares
SC 13G · Sep 19, 2022
10.0%
699K shares
SC 13D/A · Sep 16, 2022
0.0%
0 shares
SC 13D · Jul 13, 2022
28.0%
17.5M shares
SC 13G · Jul 8, 2022
2.4%
1.5M shares
SC 13G/A · Apr 11, 2022
9.3%
5.8M shares
Bain Capital Life Sciences Fund II, L.P.
SC 13G/A · Feb 14, 2022
10.0%
6.3M shares
Nikko Asset Management Americas, Inc.
SC 13G/A · Feb 14, 2022
0.0%
0 shares
Ally Bridge MedAlpha Master Fund L.P.
SC 13G/A · Feb 11, 2022
6.3%
3.9M shares
SC 13G · Feb 11, 2022
5.6%
3.5M shares